Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Managed futures stumble in October; Barclay CTA Index slides 1.50%

Wednesday, November 16, 2011
Opalesque Industry Update - After four straight months of gains, managed futures lost 1.50% in October according to the Barclay CTA Index compiled by BarclayHedge. Year-to-date, the Index is down 2.30%.

"A revival of animal spirits sparked by an improving economic picture and the appearance of a solution for Euro zone sovereign debt problems spawned trend reversals in many of the major futures sectors," says Sol Waksman, founder and president of BarclayHedge.

Six of Barclay’s eight CTA indices had negative returns in October. The Diversified Traders Index lost 2.69%, Systematic Traders were down 2.15%, Financial & Metal Traders lost 0.68%, and Currency Traders slipped 0.03%.

"As sentiment reversed from risk-off in September to risk-on in October, prices for equities and commodities rose while bond prices declined,"; says Waksman.

On the positive side, the Barclay Discretionary Traders Index gained 0.66%, and Agricultural Traders were up 0.26%.

"Since discretionary traders are typically not momentum traders, they usually do better than the crowd during market reversals," says Waksman. The largest CTAs, as measured by the Barclay BTOP50 Index, were hit hard in October, giving up 2.42%. The BTOP50 is down 3.72% in 2011. Full press release:Source

km

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its